Gastrointestinal Endoscopy
Volume 67, Issue 3 , Pages 556-560, March 2008

Endoloop ligation of large pedunculated submucosal tumors (with videos)

Current affiliations: Division of Gastroenterology (S.-H.L., J.-H.P., D.H.P., I.-K.C., H.-S.K., S.-H.P., S.-J.K.), Department of Internal Medicine, Department of Pathology (H.-D.C), Soon Chun Hyang University Cheonan Hospital, Cheonan, Korea

Received 29 November 2006; accepted 29 October 2007.

Cheonan, Korea

Background

Endoscopic treatment of a pedunculated submucosal tumor (SMT) has not been well established. In particular, endoscopic cautery snare resection of a large pedunculated SMT is discouraged because of the increased risk of bowel perforation.

Objective

To report the clinical outcome of endoloop ligation for the treatment of various pedunculated SMTs with a clip-marking technique.

Design

Prospective evaluation of 10 patients who, between June 2005 and May 2006, received endoloop ligation with a clip-marking technique.

Setting

At a tertiary-care, academic medical center.

Patients

Ten patients with various pedunculated SMTs with either symptomatic lesions or large-sized lesions (>4 cm).

Main Outcome Measurements

Clinical procedural success, reported adverse events.

Results

Nine cases were successfully treated, with tumor removal within 4 weeks. In contrast, only 1 patient needed a second session of loop ligation. Only 6 specimens were retrieved. There were no procedure-related complications, such as bleeding or perforation.

Limitations

Retrieval by the patient of a specimen from stool was possible in only 60% of cases; a limited number of 10 patients; by oncology standards, not the correct treatment for nonlipomatous lesions, which limits its application to surgical risk candidates.

Conclusions

Endoloop ligation of large pedunculated SMTs seemed to be technically feasible and appeared to be safe in this case series. Further controlled clinical trials have to be conducted before application of this technique to a large submucosal lipoma or other SMTs in surgical high-risk candidates can be generally recommended.

Abbreviation: SMT, submucosal tumor

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Presented at United European Gastroenterology Week, October 21-25, 2006, Berlin, Germany (video session).

PII: S0016-5107(07)02999-9

doi:10.1016/j.gie.2007.10.049

Gastrointestinal Endoscopy
Volume 67, Issue 3 , Pages 556-560, March 2008